Melanoma: The Practical Application of T-VEC
Keith Flaherty, MD; Jason Luke, MD, FACP; Jeffrey Weber, MD, PhD; and Rene Gonzalez, MD, assess the practical use of the immunotherapy, talimogene laherparepvec (T-VEC), in melanoma treatment.
Keith Flaherty, MD; Jason Luke, MD, FACP; Jeffrey Weber, MD, PhD; and Rene Gonzalez, MD, assess the practical use of the immunotherapy, talimogene laherparepvec (T-VEC), in melanoma treatment.